Location History:
- Harleysville, PA (US) (2014)
- North Wales, PA (US) (2014)
- Philadelphia, PA (US) (2015)
Company Filing History:
Years Active: 2014-2015
Title: Adam W. Johnson: Innovator in Neurological and Psychiatric Treatments
Introduction
Adam W. Johnson is a prominent inventor based in Philadelphia, PA, who has made significant contributions to the field of pharmaceutical sciences. With a total of three patents to his name, Johnson's work primarily focuses on developing compounds that target metabotropic glutamate receptors, particularly in relation to neurological and psychiatric disorders.
Latest Patents
Among his most notable inventions are two innovative classes of derivatives. The first is the aminomethyl biaryl benzotriazole derivatives. This invention pertains to compounds that act as potentiators of metabotropic glutamate receptors, specifically the mGluR2 receptor. These derivatives show promise in the treatment and prevention of neurological and psychiatric disorders linked to glutamate dysfunction. They also pertain to pharmaceutical compositions that utilize these compounds for therapeutic purposes.
The second set of inventions involves ether benzotriazole derivatives. Similar to the aminomethyl biaryl benzotriazole derivatives, these compounds are designed to enhance the activity of the mGluR2 receptor. The significance of this invention lies in its potential applications in addressing various diseases associated with metabotropic glutamate receptors and their involvement in neurological conditions.
Career Highlights
Adam W. Johnson is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His tenure at Merck has been marked by a continuous endeavor to innovate and improve treatment options for patients suffering from complex mental health disorders and neurological conditions.
Collaborations
Throughout his career, Johnson has collaborated with other esteemed professionals in the field, notably Douglas C. Beshore and Robert M. Garbaccio. These partnerships have fostered a productive environment for research and development, enabling the exploration of new therapeutic avenues.
Conclusion
In summary, Adam W. Johnson's contributions through his patents significantly advance the treatment landscape for neurological and psychiatric disorders. His innovative spirit and dedication to pharmaceutical research continue to pave the way for future advancements in medicine, underscoring the importance of inventions in the realm of healthcare.